drugset / Trial / NCT02402283

Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate

NCT02402283

Phase 1 Completed 20 enrolled Verisfield UK Ltd. Greek Branch
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to determine the bioequivalence of Metronidazole benzoate (400 mg metronidazole per sachet oral granules)/Terix Labs Ltd and Flagyl™ 400 mg Tablets (400 mg metronidazole per film coated tablet)/Zentiva.

Timeline

Start
2015-05
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 400 mg Oral

Indications

No indication recorded.